Join Dr. Adrian Culf from the Atlantic Cancer Reasearch Institute for his seminar on "Isoenzyme-selective histone deacetylase (HDAC) inhibitors: HDAC6 in human breast and prostate cancer cell lines," on Wednesday, January 30 at 12:30 pm.